David J. Mazzo - Jan 9, 2024 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Signature
James Nisco, Attorney-in-Fact for David J. Mazzo
Stock symbol
LSTA
Transactions as of
Jan 9, 2024
Transactions value $
-$72,152
Form type
4
Date filed
1/11/2024, 04:10 PM
Previous filing
Jan 17, 2023
Next filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $0 +94K +89.26% $0.00 199K Jan 9, 2024 Direct F1, F2
transaction LSTA Common Stock Tax liability -$37.6K -12.2K -6.12% $3.08 187K Jan 9, 2024 Direct F2, F3
transaction LSTA Common Stock Tax liability -$24.2K -7.84K -4.19% $3.08 179K Jan 9, 2024 Direct F2, F3
transaction LSTA Common Stock Tax liability -$10.4K -3.47K -1.94% $3.00 176K Jan 10, 2024 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LSTA Stock Option (Right to Buy) Award $0 +47K $0.00 47K Jan 9, 2024 Common Stock 47K $3.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 94,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2 Includes 115,850 unvested restricted stock.
F3 Shares withheld as payment of a tax liability on vesting of restricted stock.
F4 Includes 109,166 unvested restricted stock.
F5 One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.